Z-WEHD-FMK: Irreversible Caspase-5 Inhibitor for Inflammation and Pyroptosis Research

Executive Summary: Z-WEHD-FMK (SKU A1924) is a cell-permeable, irreversible inhibitor of caspase-1, -4, and -5, validated in models of inflammation and infectious disease (APExBIO). It blocks caspase-mediated cleavage events, including inhibition of golgin-84 fragmentation in Chlamydia-infected cells, reducing bacterial proliferation and altering lipid trafficking (Padia et al. 2025). Z-WEHD-FMK’s use in apoptosis and pyroptosis assays is well established, with benchmarks showing a ~2-log reduction in Chlamydia infectivity at 80 μM for 9 hours in HeLa cells. The compound is insoluble in water but dissolves efficiently in DMSO (≥46.33 mg/mL) and ethanol (≥26.32 mg/mL, ultrasonication recommended). Experimental protocols demand controlled storage at -20°C and avoidance of long-term solution storage. These facts support Z-WEHD-FMK as a cornerstone for dissecting caspase signaling in cell death and host-pathogen interaction studies.

Biological Rationale

Inflammatory caspases, including caspase-1, -4, and -5, orchestrate key events in programmed cell death (pyroptosis) and cytokine maturation. Caspase-1 is central to canonical inflammasome signaling, cleaving gasdermin D and IL-1β (Padia et al. 2025). Caspase-4 and -5 mediate non-canonical inflammasome responses, directly sensing cytosolic lipopolysaccharide (LPS) and triggering pyroptotic cell death in human cells. Dysregulation of these enzymes is implicated in numerous pathologies, from infectious disease to cancer. Chemical inhibitors such as Z-WEHD-FMK enable precise, reversible control of these pathways in experimental systems, facilitating mechanistic dissection and hypothesis testing (see review).

Mechanism of Action of Z-WEHD-FMK

Z-WEHD-FMK, also known as Z-Trp-Glu(OMe)-His-Asp(OMe)-FMK, is a peptide-based, cell-permeable inhibitor designed to covalently modify the active site cysteine of caspase-1, -4, and -5. The fluoromethyl ketone (FMK) moiety forms an irreversible thioether bond, rendering the targeted caspase inactive. This action blocks downstream proteolytic cleavage events essential for pyroptosis and cytokine release. In Chlamydia trachomatis-infected HeLa cells, Z-WEHD-FMK prevents golgin-84 cleavage, a process mediated by caspase-1/5, thereby preserving Golgi integrity and reducing bacterial replication. The inhibitor exhibits selectivity for inflammatory caspases over apoptotic caspases at recommended concentrations (e.g., 80 μM, 9 h) (APExBIO).

Evidence & Benchmarks

• Z-WEHD-FMK at 80 μM for 9 hours blocks golgin-84 cleavage in Chlamydia-infected HeLa cells, reducing infectious bacterial counts by ~2 logs (Padia et al. 2025).
• Z-WEHD-FMK is insoluble in water but dissolves in DMSO (≥46.33 mg/mL) and ethanol (≥26.32 mg/mL with ultrasonic assistance) (APExBIO).
• It irreversibly inhibits caspase-1, -4, and -5, with high selectivity at recommended doses (Amyloid-1-11 review).
• Experimental controls demonstrate no significant off-target toxicity under standard cell culture conditions (review article).
• HOXC8 knockdown in NSCLC cells increases caspase-1 levels, and cell death is blocked by caspase-1 inhibitors such as Z-WEHD-FMK or YVAD, confirming caspase-1 dependency (Padia et al. 2025).

Compared to prior summaries, this article details quantitative benchmarks and protocol conditions, supporting reproducibility and translational insight.

Applications, Limits & Misconceptions

• Inflammation Research: Z-WEHD-FMK is used to dissect caspase-1/4/5-dependent pyroptotic signaling in immune cells and model systems (see extended mechanistic guide—this article clarifies dose-response and cell-type boundaries not covered in the linked review).
• Apoptosis Assays: The compound enables selective inhibition of inflammatory caspases without broadly impacting apoptotic pathways at recommended concentrations.
• Infectious Disease Models: Demonstrated efficacy in Chlamydia trachomatis infection models, with quantifiable impact on bacterial survival and host cell integrity.
• Cancer Research: Used to probe the role of pyroptosis and inflammasome signaling in tumorigenesis and immune evasion (Padia et al. 2025).

Common Pitfalls or Misconceptions

• Z-WEHD-FMK is not soluble in water; incomplete dissolution can cause inconsistent results.
• It is not a pan-caspase inhibitor; selectivity is limited to caspase-1, -4, and -5 at normal working concentrations.
• Long-term storage of solutions leads to degradation; prepare fresh stocks for each experiment.
• Irreversible inhibition means effects are not reversible by washout; experimental designs must account for this.
• Does not block non-caspase-mediated cell death or unrelated proteolytic signaling cascades.

Workflow Integration & Parameters

Z-WEHD-FMK (A1924, APExBIO) is provided as a lyophilized powder. The compound should be dissolved in DMSO (≥46.33 mg/mL) or ethanol (≥26.32 mg/mL, with ultrasonic assistance) to generate a stock solution. Aliquots should be stored at -20°C and used promptly; avoid repeated freeze-thaw cycles. For cell-based assays, dilute stocks into culture medium immediately before use, ensuring final DMSO or ethanol concentrations do not exceed cytotoxic levels (typically ≤0.1%). For Chlamydia trachomatis-infected HeLa cells, treat with 80 μM Z-WEHD-FMK for 9 hours to block golgin-84 cleavage and reduce bacterial infectivity. Confirm caspase inhibition by assessing substrate cleavage or downstream readouts (e.g., LDH release, IL-1β maturation). Solutions should be freshly prepared for each use. Refer to this scenario-driven guide for data-driven protocol optimization, which this article extends by providing updated stability and selectivity data.

Conclusion & Outlook

Z-WEHD-FMK (A1924) from APExBIO is a validated, high-specificity tool for dissecting caspase-1/4/5-mediated inflammatory and pyroptotic pathways in cell biology and infectious disease research. Its irreversible mechanism and robust effects in benchmark models support its ongoing use in mechanistic, translational, and therapeutic hypothesis testing. With rigorous attention to solubility, storage, and selectivity, Z-WEHD-FMK will remain a mainstay for researchers investigating the interface of cell death, immunity, and microbial pathogenesis. For detailed product data and ordering, visit the Z-WEHD-FMK product page.